retatrutide triple agonist glp-1 gip glucagon receptors phase 2 obesity trial is gaining attention in metabolic research for its activity on GIP, GLP-1, and retatrutide triple agonist glp-1 gip
Pay in 4 interest-free payments of $7.27 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2




























